Chinese VC spending on US biotech hit by security reviews

Chinese venture capital investment in US biotech companies fell by more than half in the first half of the year as Washington tightened scrutiny of funding from overseas, raising fears that US…

CONTINUE READING»

Stay up-to-date

Subscribe now for weekly news headlines roundup delivered directly to your inbox.

Thank you for subscribing.

Something went wrong.